Evidence map›Paper›PMID 25888676›Full record

ArticleJPEN. Journal of parenteral and enteral nutrition2016

Nutrition Modulation of Cardiotoxicity and Anticancer Efficacy Related to Doxorubicin Chemotherapy by Glutamine and ω-3 Polyunsaturated Fatty Acids.

Hongyu Xue, Wenhua Ren, Melanie Denkinger, Ewald Schlotzer, Paul E Wischmeyer

Abstract read
In one paragraph

Article in JPEN. Journal of parenteral and enteral nutrition, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. [Omega-3 polyunsaturated fatty acids in pediatric patients with acute lymphoblastic leukemia].Revista medica del Instituto Mexicano del Seguro Social · 2025
    Review
  6. Article
  7. Endothelial-to-Mesenchymal Transition: Potential Target of Doxorubicin-Induced Cardiotoxicity.American journal of cardiovascular drugs : drugs, devices, and other interventions · 2023
    Review
  8. Article
  9. Article
  10. Contribution of n-3 Long-Chain Polyunsaturated Fatty Acids to the Prevention of Breast Cancer Risk Factors.International journal of environmental research and public health · 2022
    Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Hongyu XueDepartment of Anesthesiology, University of Colorado Denver, Aurora, Colorado Hongyu.Xue@ucdenver.edu.
Wenhua RenDepartment of Anesthesiology, University of Colorado Denver, Aurora, Colorado.
Melanie DenkingerFresenius Kabi, Bad Homburg, Germany.
Ewald SchlotzerFresenius Kabi, Bad Homburg, Germany.
Paul E WischmeyerDepartment of Anesthesiology, University of Colorado Denver, Aurora, Colorado.
University of Colorado Denver · USFresenius (Germany) · DE

Funding

Mechanism of Heat Shock Protein Induction by GlutamineR01GM078312 · NIGMS · UNIVERSITY OF COLORADO DENVER · PI WISCHMEYER, PAUL E · 2008 to 2012
$1.3M
NIGMS NIH HHS R01 GM078312
6 · The paper itself

Abstract

backgroundDoxorubicin (DOX) has been one of the most effective antitumor agents against a broad spectrum of malignancies. However, DOX-induced cardiotoxicity forms the major cumulative dose-limiting factor. Glutamine and ω-3 polyunsaturated fatty acids (PUFAs) are putatively cardioprotective during various stresses and/or have potential chemosensitizing effects during cancer chemotherapy.

methodsAntitumor activity and cardiotoxicity of DOX treatment were evaluated simultaneously in a MatBIII mammary adenocarcinoma tumor-bearing rat model treated with DOX (cumulative dose 12 mg/kg). Single or combined treatment of parenteral glutamine (0.35 g/kg) and ω-3 PUFAs (0.19 g/kg eicosapentaenoic acid and 0.18 g/kg docosahexaenoic acid) was administered every other day, starting 6 days before chemotherapy initiation until the end of study (day 50).

resultsGlutamine alone significantly prevented DOX-related deterioration of cardiac function, reduced serum cardiac troponin I levels, and diminished cardiac lipid peroxidation while not affecting tumor inhibition kinetics. Single ω-3 PUFA treatment significantly enhanced antitumor activity of DOX associated with intensified tumoral oxidative stress and enhanced tumoral DOX concentration while not potentiating cardiac dysfunction or increasing cardiac oxidative stress. Intriguingly, providing glutamine and ω-3 PUFAs together did not consistently confer a greater benefit; conversely, individual benefits on cardiotoxicity and chemosensitization were mostly attenuated or completely lost when combined.

conclusionsOur data demonstrate an interesting differentiality or even dichotomy in the response of tumor and host to single parenteral glutamine and ω-3 PUFA treatments. The intriguing glutamine × ω-3 PUFA interaction observed draws into question the common assumption that there are additive benefits of combinations of nutrients that are beneficial on an individual basis.

Indexed as

AnimalsAntineoplastic AgentsApoptosisArginaseCardiotoxicityCaspase 3DoxorubicinFatty Acids, Omega-3FemaleGlutamineHeartHomeostasisHSP70 Heat-Shock ProteinsLipid PeroxidationMyocytes, CardiacNutritional StatusAntineoplastic AgentsArginaseCasp3 protein, ratCaspase 3DoxorubicinFatty Acids, Omega-3GlutamineHSP70 Heat-Shock ProteinsPoly(ADP-ribose) PolymerasesTroponinamino acidsbreast cancercardiotoxicitydoxorubicinfatty acidsglutamineoncologyresearch and diseases

Identifiers

PMID25888676
PMCPMC5545109
OpenAlexW2085322826

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.